The grand NHS shake-up

The US costs are twice (!!!) as high as the UK's.
The idea that a lack of a mandate is a significant part of the bloated costs is a really extraordinary claim.
That claim is well understood and is at least 40 years old. George Akerlof won a Nobel (economics) award for this paper (PDF) all about it. No it isn't extraordinary, and the data backs it up resoundingly. The US is the only OECD country without compulsory universal health insurance, and the cost of US healthcare is 50% higher than the next most expensive country, and two and a half times the OECD average (2008 data, in internationally cost-of-living adjusted USD). See the OECD link in post 72 for the data.

Regarding "market failure of adverse selection", what do you mean?
Here is wikipedia's text. Here is a fairly plain English article about the folly of the US's lack of universality.

And, none of this is relevant to offering more, market-driven choice in health care services which is what Europeans do (and what the UK could, and should IMO do more of). The notion that any OECD country would voluntarily move to the US health system model is pretty fanciful.
 
I'll ask again - you really don't know?
Perhaps you'd be civil enough to answer my question first. In what way is what you describe an incentive?
Can you show from the bill itself how it will improve the UK health system so that it provides the better standard of care that you are claiming it will do?
And I have not made that claim either. For easy reference, my claim, in post 40, is:

"IMO the major positive about private provision of med services [ . . . ] is to increase the supply of health care services. We already know that the demand is going to soar. Mushrooming demand with unchanged supply needs to violate commonly accepted economics in order not to result in spiralling costs."
 
<snip>

Competion works fine in the provision of health care services.

I disagree. Competition only works when consumers have sufficient information and ability to make good choices.

What statistics should be published to allow patients to select one treatment, physician or medical facility over others?

How well will these statistics correlate with best medical care?

For example, should a surgeon with a relatively high death rate amongst her patients be avoided? Most people would probably think so, and without more detailed information it's a reasonable conclusion. But what if she deals with the most difficult cases? How could that piece of information be represented in the statistics without making them even harder to understand?

People have been conditioned to think more choice is automatically better than less choice. The reality is that more choice is only better if you have detailed enough information on relevant factors along with the ability to interpret it correctly.

The vast majority of patients will have neither enough information nor the ability to interpret the information that is available about providers of healthcare.
 
Perhaps you'd be civil enough to answer my question first. In what way is what you describe an incentive?

I am surprised that you didn't know but one incentive is simply to do their job better.

And I have not made that claim either. For easy reference, my claim, in post 40, is:

"IMO the major positive about private provision of med services [ . . . ] is to increase the supply of health care services. We already know that the demand is going to soar. Mushrooming demand with unchanged supply needs to violate commonly accepted economics in order not to result in spiralling costs."

Then your comments do not, to quote yourself ".. seem relevant to government health care policies / proposals" that are being discussed in this thread.
 
I disagree. Competition only works when consumers have sufficient information and ability to make good choices.

What statistics should be published to allow patients to select one treatment, physician or medical facility over others?

How well will these statistics correlate with best medical care?

For example, should a surgeon with a relatively high death rate amongst her patients be avoided? Most people would probably think so, and without more detailed information it's a reasonable conclusion. But what if she deals with the most difficult cases? How could that piece of information be represented in the statistics without making them even harder to understand?

People have been conditioned to think more choice is automatically better than less choice. The reality is that more choice is only better if you have detailed enough information on relevant factors along with the ability to interpret it correctly.

The vast majority of patients will have neither enough information nor the ability to interpret the information that is available about providers of healthcare.


And where in this "grand NHS shake-up" are such things being planned for?

Seems a lot of people want to discuss the abstract rather than what is actually being planned. I'm more interested in discussing what is going to be implemented if nothing is changed.
 
What statistics should be published to allow patients to select one treatment, physician or medical facility over others?
See section 2, page 13 (PDF).

The vast majority of patients will have neither enough information nor the ability to interpret the information that is available about providers of healthcare.
That may be true or it may not. It also may not matter if the marginal patients that do influence provision across the board. Then even if the majority of patients stayed local, they could see provision improve. IMO it takes an unhelpfully paternalistic view to prefer the non-disclosure of information and the relative absence of patient choice. And I don't think that the surveys agree with that.
 
I am surprised that you didn't know but one incentive is simply to do their job better.
And how is that helped by keeping out cost versus benefit incentives?

Then your comments do not, to quote yourself ".. seem relevant to government health care policies / proposals" that are being discussed in this thread.
My comments are relevant to increased private provision of health care services. Are you claiming that nothing in the proposed "NHS shake up" will do that?
 
Seems a lot of people want to discuss the abstract rather than what is actually being planned. I'm more interested in discussing what is going to be implemented if nothing is changed.
I disagree that discussing the content of the July 2010 white paper, which "sets out the Government's long-term vision for the future of the NHS" (and is somewhat more amenable than a parliamentary bill) is dealing with "the abstract".

But bringing up things like privatising national health insurance (IE not funding it publicly) and shifting the cost of delivery to patients surely is.
 
See section 2, page 13 (PDF).

Oh dear. Looks like we'll be having a lot more homoeopathy and other "alternative" medicine on the NHS then. Alternative practitioners are very good at pleasing their patients. On the other hand doctors like my GP, who is a quiet, thoughtful (i.e. he thinks before he speaks) man, is likely to do poorly on such measures of patient experience.

That may be true or it may not.

It is true and always will be.

Patients' assessment of their medical care is often based on superficial factors not related to outcomes, such as bedside manner and entertainment facilities.

Performance statistics by their very nature often gloss over important details. E.g., league tables for schools now include contextual-value-added scores to try to capture the improvement in pupils' performance from 11-16.

It's very difficult to summarise complex data in a way that is both understandable to a lay audience and still contains all the important information required to make informed decisions.

It also may not matter if the marginal patients that do influence provision across the board. Then even if the majority of patients stayed local, they could see provision improve.

Unfortunately there will be many more patients directing the course of healthcare in the UK based on ignorance, biased information and misinterpretation of statistics.

IMO it takes an unhelpfully paternalistic view to prefer the non-disclosure of information and the relative absence of patient choice. And I don't think that the surveys agree with that.

I'm sorry reality isn't helpful to Mr. Lansley's vision. But there's a reason we send people to medical school for 5 years and then train them for several years after they graduate: it's because it takes that long to gather enough knowledge and skills to practice medicine. I.e. make sensible choices about the diagnosis and treatment of medical problems.

That's not to say patients should be kept in the dark about their medical condition or left out of choices about their treatment. But that doesn't require patients to be given the responsibility of having to interpret medical statistics when they are often in pain, desperate and at their most vulnerable.
 
Which wasn't my claim. "Health care is overwhelmingly privately provided" was. GPs are part of the private provision of health care.

Perhaps you could elaborate? I always thought that GPs were paid by the NHS, and that the NHS was funded by taxpayer money.
 
That may be true or it may not. It also may not matter if the marginal patients that do influence provision across the board. Then even if the majority of patients stayed local, they could see provision improve.

Do you not see increased requests for homeopathy, increased influence of tabloid scare stories, and increased influence of big pharma PR departments as at least a potential worry?

What about the impact of richer people being able to travel much further to choose their doctors? Does it not worry you that the poor and infirm will be incapable of travelling such distances to acquire better healthcare, and so will on average recieve lower quality healthcare?

I don't see a tory plan for any of these eventualities.
 
That claim is well understood and is at least 40 years old. George Akerlof won a Nobel (economics) award for this paper (PDF) all about it. No it isn't extraordinary, and the data backs it up resoundingly. The US is the only OECD country without compulsory universal health insurance, and the cost of US healthcare is 50% higher than the next most expensive country, and two and a half times the OECD average (2008 data, in internationally cost-of-living adjusted USD). See the OECD link in post 72 for the data.

Yes, I know adverse selection is a real effect, but it's a huge leap to assume that it's a significant cause of the US's bloated costs. Recissions, gag clauses, and all the other tricks market-based third party payers invent to deny consumers health care could easily counteract or even eclipse whatever effects exist from the lack of a mandate.



And, none of this is relevant to offering more, market-driven choice in health care services which is what Europeans do (and what the UK could, and should IMO do more of). The notion that any OECD country would voluntarily move to the US health system model is pretty fanciful.

The exclusive use of market-based "solutions" to health care needs in the US (no public lab services, no public dialysis companies, private insurance companies hired to manage Medicare and Medicaid, etc etc etc) is the only plausible explanation I can think of for why our public health care expenditures can only cover a fraction of our population, for the same per capita cost that the NHS covers the entire population.
 
The notion that any OECD country would voluntarily move to the US health system model is pretty fanciful.

And as to that - we didn't "voluntarily" choose to have any of these reforms. Neither of the parties in government included these changes in their manifesto, and the tories explicitly stated they wouldn't be making these changes. If we move towards more market based healthcare it won't have been voluntary, and the same rule applies to moving even further towards the american system if the condems can pull it off within 5 years.
 
Perhaps you could elaborate? I always thought that GPs were paid by the NHS, and that the NHS was funded by taxpayer money.
But GPs are self-employed contractors. And in a couple of hundred cases GP practices are owned by consortia of the GPs themselves and private corporations, or exclusively private companies. A practice has a service requirement to take all patients from the area it locates in, but individual GPs decide how much of their time/service they want to contract to the NHS or otherwise. (NHS PDF) (Wikipedia) (QOF data)

It is not correct to regard them as state employees, even though most of them derive most of their income from their contract with the NHS.
 
Yes, I know adverse selection is a real effect
Well in post 82 you didn't know what it was.

Recissions, gag clauses, and all the other tricks market-based third party payers invent to deny consumers health care could easily counteract or even eclipse whatever effects exist from the lack of a mandate.
Recissions and denials of cover are direct consequences of the absence of any universal mandate. If there is a statutory entitlement to health cover (as there is in all UHC systems in all countries that have them), then these phenomena do not arise. Some medical treatments are not provided by some universal systems, but basic health care, chronic conditions, major medical, emergency, maternity, and so on always are.

Gag clauses are supposed to be illegal for health management organisations even in the US. But that is a question of enforceable regulation, not universality.

The exclusive use of market-based "solutions" to health care needs in the US (no public lab services, no public dialysis companies, private insurance companies hired to manage Medicare and Medicaid, etc etc etc) is the only plausible explanation I can think of for why our public health care expenditures can only cover a fraction of our population, for the same per capita cost that the NHS covers the entire population.
Non-universality isn't the only plausible reason for higher cost-per-outcome in the US. One of the reasons is higher income per person in the US than most other countries. The others are well covered in a 2008 McKinsey report (PDF). But in my view the principal reason why all the supply/demand incentives in the US push costs upwards is in most cases tied back to no statutory entitlements (non-universality). Hence in other countries, market-obtained provision (even the insurance provision in most countries) does not manage to overwhelm state buying power.
 
Last edited:
And as to that - we didn't "voluntarily" choose to have any of these reforms.
Not really what I mean. No non-US OECD government will--in my view--abandon* a universal health system on behalf of their citizens in favour of a US model.

I agree that the health bill wasn't in the Tory manifesto. But it isn't a move away from universal health insurance either.

*Actually if demographic-induced burdens on states became extreme enough, I would not rule out the idea that some health cover became means tested, although I have never heard any politician utter anything like this.
 
Well in post 82 you didn't know what it was.

You worded it as though it was separate from the effect from a lack of a mandate, and additionally I was wondering what you consider a market failure in health care to be, seeing as how the private sector would be perfectly content for things like even basic cancer treatments to be the health care free market equivalent to luxury items such as penthouses, new sports cars, and yachts, so long as the margins are high enough.

Recissions and denials of cover are direct consequences of the absence of any universal mandate.
The private sector payers in the US have become phenomenally creative with coming up with ways of serving shareholders at the expense of policyholders. I think that might be because the whole idea of third party payers, right off the bat, are in violation of basic market principals. Where people pay out of pocket, the market is more effective.

If there is a statutory entitlement to health cover (as there is in all UHC systems in all countries that have them), then these phenomena do not arise. Some medical treatments are not provided by some universal systems, but basic health care, chronic conditions, major medical, emergency, maternity, and so on always are.

Gag clauses are supposed to be illegal for health management organisations even in the US. But that is a question of enforceable regulation, not universality.

Gag clauses are supposed to be illegal now, but that's just one of many, many inventions the private sector has created over the years to enrich investors at the expense of patients.

Non-universality isn't the only plausible reason for higher cost-per-outcome in the US.

I never said it was, and in fact, my post argued the opposite (no nationalized lab services, etc. being behind the the inflated costs (relative to the other developed nations) for the universal coverage after age 65 with Medicare.)

One of the reasons is higher income per person in the US than most other countries.

"Per person" is an average (not a literal average, but taking both into account) between rich and poor, right? How does that even work in a plutonomy?


But in my view the principal reason why all the supply/demand incentives in the US push costs upwards is in most cases tied back to no statutory entitlements (non-universality). Hence in other countries, market-obtained provision (even the insurance provision in most countries) does not manage to overwhelm state buying power.

There is universality in the over 65 age group (the biggest health care consumers of all, everywhere), and the Medicare costs are way off the chart compared to the other developed nations for the same age group. The question is: where is all the US Medicare money going? Once you start trying to answer that question by looking at the differences in the US system compared to everyone else, you see in pretty clear detail how sometimes anti-market initiatives and government resource allocations are more effective in terms of most people's values than the market is.
 
Last edited:
It is not correct to regard them as state employees, even though most of them derive most of their income from their contract with the NHS.

That they are individuals "contracted" instead of "employed" is an insignificant difference compared to the basic, usual definition of public sector vs private. My garbage man could be "contracted" on a day to day or month to month basis via a gov run temp agency, instead of being a literal gov employee, and it wouldn't change the fact that garbage collection in my city is publicly provided.
 
You worded it as though it was separate from the effect from a lack of a mandate, and additionally I was wondering what you consider a market failure in health care to be
Adverse selection is a market failure, which means that voluntary actions don't bring about the most efficient outcome. In the case of health insurance, adverse selection arises if insurance enrolment is voluntary, or partly voluntary. It is compulsory in UHC systems and not in the US (the fact that it is paid for collectively by employers for some groups, and by the federal government for military and Medicaid/are prevents a worse failure than if it was completely voluntary. The links I gave are all over this.

I think that might be because the whole idea of third party payers, right off the bat, are in violation of basic market principals. Where people pay out of pocket, the market is more effective.
That's a separate issue (mentioned in the McKinsey report) and you are correct that things (including a lot of healthcare stuff, but not alal of it) are overconsumed if provided free-at-delivery. But that backfires on people when premiums soar afterwards. Hence statutory entitlements are, and should remain, the role of a public regulator. That does not, however, mean that the public sector needs to supply what patients are entitled to on a captive basis.

"Per person" is an average (not a literal average, but taking both into account) between rich and poor, right? How does that even work in a plutonomy?
It's one of the often repeated arguments for why America spends more on health (normally by people interested in defending the very high cost of US medical care, which is not exactly what I am doing, but in the interest of fairness I would concede this point to some extent)

There is universality in the over 65 age group (the biggest health care consumers of all, everywhere), and the Medicare costs are way off the chart compared to the other developed nations for the same age group. The question is: where is all the US Medicare money going? Once you start trying to answer that question by looking at the differences in the US system compared to everyone else, you see in pretty clear detail how sometimes anti-market initiatives and government resource allocations are more effective in terms of most people's values than the market is.
Statutory entitlements (which may be what you mean by the highlight) are, should be, and will be decided by a central government agency in the UK. IMO Medicare is an illustration that governments can screw this up too. Since Medicare is only relevant to a minority of the population in the US, then it falls prey to special interest lobbies which extract disproportionate gains for that group paid for by the working population. If the over 65s were subject to the same basic statutory health care entitlement as everyone, that wouldn't happen so easily. So again--I think you can tie it back to non-universality ("partial" universality being non-universality)
 

ISF - Join now!

Every member here is approved by hand. No bots, no spam, just people who care about evidence and honest debate.

Membership is free!

Create your free account

Back
Top Bottom